StockData
Labcorp Holdings Inc. logo

Labcorp Holdings Inc. (LH) stock

LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$372.46+1.98 (+0.53%)

Close on Nov 16, 2026Market cap $30.24BP/E 30.6Yield 0.77%

Labcorp cash

Cash and short-term investments held at the end of each period.

Labcorp's cash was $261.80M at Sep 30, 2026. For fiscal 2025 it was $532.30M, down 65.0% from the year before. Over ten years it grew -2.9% a year on average. The highest annual figure on record is $1.52B in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$532.30M-65.0%
FY2024Dec 31, 2024$1.52B+182.9%
FY2023Dec 31, 2023$536.80M+67.4%
FY2022Dec 31, 2022$320.60M-76.8%
FY2021Dec 31, 2021$1.38B+4.6%
FY2020Dec 31, 2020$1.32B+291.3%
FY2019Dec 31, 2019$337.50M-20.9%
FY2018Dec 31, 2018$426.80M+34.8%
FY2017Dec 31, 2017$316.60M-27.0%
FY2016Dec 31, 2016$433.60M-39.5%
FY2015Dec 31, 2015$716.40M+23.5%
FY2014Dec 31, 2014$580.00M+43.6%
FY2013Dec 31, 2013$404.00M0.0%
FY2012Dec 31, 2012$404.00M-13.5%
FY2011Dec 31, 2011$466.80M+193.0%
FY2010Dec 31, 2010$159.30M+7.3%
FY2009Dec 31, 2009$148.50M-32.4%
FY2008Dec 31, 2008$219.70M+289.5%
FY2007Dec 31, 2007$56.40M+9.5%
FY2006Dec 31, 2006$51.50M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$261.80M-56.2%
Q2 FY2026Jun 30, 2026$141.80M-78.1%
Q1 FY2026Mar 31, 2026$981.10M+165.6%
Q4 FY2025Dec 31, 2025$532.30M-65.0%
Q3 FY2025Sep 30, 2025$598.10M-60.6%
Q2 FY2025Jun 30, 2025$647.30M+144.2%
Q1 FY2025Mar 31, 2025$369.40M+272.0%
Q4 FY2024Dec 31, 2024$1.52B+182.9%
Q3 FY2024Sep 30, 2024$1.52B+108.4%
Q2 FY2024Jun 30, 2024$265.10M-86.3%
Q1 FY2024Mar 31, 2024$99.30M-74.8%
Q4 FY2023Dec 31, 2023$536.80M+67.4%
Q3 FY2023Sep 30, 2023$727.90M+77.6%
Q2 FY2023Jun 30, 2023$1.93B+97.3%
Q1 FY2023Mar 31, 2023$393.90M-68.1%
Q4 FY2022Dec 31, 2022$320.60M-76.8%
Q3 FY2022Sep 30, 2022$409.90M-79.9%
Q2 FY2022Jun 30, 2022$978.30M-50.2%
Q1 FY2022Mar 31, 2022$1.23B-34.8%
Q4 FY2021Dec 31, 2021$1.38B+4.6%
Q3 FY2021Sep 30, 2021$2.04B+205.2%
Q2 FY2021Jun 30, 2021$1.96B+252.5%
Q1 FY2021Mar 31, 2021$1.89B+484.3%
Q4 FY2020Dec 31, 2020$1.32B+291.3%
Q3 FY2020Sep 30, 2020$667.20M+84.8%
Q2 FY2020Jun 30, 2020$557.00M+109.9%
Q1 FY2020Mar 31, 2020$323.60M-7.2%
Q4 FY2019Dec 31, 2019$337.50M-20.9%
Q3 FY2019Sep 30, 2019$361.10M-59.5%
Q2 FY2019Jun 30, 2019$265.40M-70.3%
Q1 FY2019Mar 31, 2019$348.80M-3.6%
Q4 FY2018Dec 31, 2018$426.80M+34.8%
Q3 FY2018Sep 30, 2018$892.60M+118.1%
Q2 FY2018Jun 30, 2018$892.60M+197.6%
Q1 FY2018Mar 31, 2018$361.80M-1.0%
Q4 FY2017Dec 31, 2017$316.60M-27.0%
Q3 FY2017Sep 30, 2017$409.30M–
Q2 FY2017Jun 30, 2017$299.90M–
Q1 FY2017Mar 31, 2017$365.50M–
Q4 FY2016Dec 31, 2016$433.60M–

More Labcorp figures

See a number that looks wrong?